China Meheco Group announced that its subsidiary, Tianfang Pharmaceutical, has received the approval from the National Medical Products Administration to issue the Approval Notice for Supplementary Application of Betahistine Hydrochloride Tablets. The product passed the consistency evaluation of generic drugs in terms of quality and efficacy. Betahistine hydrochloride tablets are mainly used to treat symptoms related to Meniere's disease, and the original drug was produced by Serc.
中国医药：子公司天方药业盐酸倍他司汀片通过仿制药一致性评价
China Meheco Group: The subsidiary Tianfang Pharmaceutical's Generic Consistency Evaluation of Rosuvastatin Calcium Tablets has been approved.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.